发明名称 INHIBITION OF MATRIX METALLOPROTEASES BY ACETYLENE CONTAINING COMPOUNDS
摘要 Matrix metalloprotease inhibiting compounds, pharmaceutical compositions thereof and a method of disease treatment using such compounds are presented. The compounds of the invention have the generalized formula (I) where R<15> is selected from the group comprising: HOCH2, MeOCH2, (n-Pr)2NCH2, CH3CO2CH2, EtOCO2CH2, HO(CH2)2, CH3CO2(CH2)2, HO2C(CH2)2, OHC(CH2)3, HO(CH2)4, Ph, 3-HO-Ph, and PhCH2OCH2; and R<16> is (a) or (b). These compounds are useful for inhibiting matrix metalloproteases and, therefore, combating conditions to which MMP's contribute, such as osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis, bullosa, conditions leading to inflammatory responses, osteopenias mediated by MMP activity, tempero mandibular joint disease, demyelating diseases of the nervous system, tumor metastasis or degenerative cartilage loss following traumatic joint injury, and coronary thrombosis from athrosclerotic plate rupture. The present invention also provides pharmaceutical compositions and methods for treating such conditions.
申请公布号 WO9743245(A1) 申请公布日期 1997.11.20
申请号 WO1997US07921 申请日期 1997.05.12
申请人 BAYER CORPORATION;DIXON, BRIAN, R.;CHEN, JINSHAN 发明人 DIXON, BRIAN, R.;CHEN, JINSHAN
分类号 A61K31/40;A61K31/19;A61K31/195;A61K31/215;A61K31/403;A61K31/4035;A61P1/02;A61P9/00;A61P13/02;A61P15/00;A61P17/00;A61P25/00;A61P27/02;A61P29/00;A61P35/00;A61P35/02;A61P43/00;C07C59/84;C07C59/90;C07C59/92;C07C69/145;C07C69/95;C07C69/96;C07C229/34;C07C229/38;C07D209/48;(IPC1-7):C07C229/34 主分类号 A61K31/40
代理机构 代理人
主权项
地址